Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Android iOS
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Search results for:

alogliptin-pioglitazone

alogliptin-pioglitazone
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Oseni TABLET, ORAL 12.5 mg-15 mg, 12.5 mg-30 mg, 12.5 mg- 45 mg    
Oseni TABLET, ORAL 25 mg-15 mg, 25 mg-30 mg, 25 mg-45 mg    
Comments:

Oseni medication guide

This is a combination of alogliptin and pioglitazone in 6 different strengths, dosed once daily.  Non-formulary, not stocked, give 2 drugs separately in same strengths dosed once daily.

Reviewed: July 25, 2013 (Oseni)

Last updated: Dec. 19, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved